PRECIPIO INC (PRPO) Stock Price, Forecast & Analysis
NASDAQ:PRPO • US74019L6020
PRPO Key Statistics, Chart & Performance
The current stock price of PRPO is 23.39 USD. In the past month the price decreased by -2.54%. In the past year, price increased by 223.86%.
PRPO Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to PRPO. When comparing the yearly performance of all stocks, PRPO is one of the better performing stocks in the market, outperforming 97.98% of all stocks.
PRPO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PRPO. PRPO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
PRPO Financial Highlights
Over the last trailing twelve months PRPO reported a non-GAAP Earnings per Share(EPS) of -0.83. The EPS increased by 59.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.93% | ||
| ROE | -9.12% | ||
| Debt/Equity | 0.06 |
PRPO Forecast & Estimates
PRPO Ownership
PRPO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.84 | 98.927B | ||
| CI | THE CIGNA GROUP | 9.32 | 75.774B | ||
| LH | LABCORP HOLDINGS INC | 15.69 | 23.055B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.68 | 23.011B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 92.25 | 22.794B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.24B | ||
| DVA | DAVITA INC | 11.26 | 10.28B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 28.36 | 6.815B | ||
| CHE | CHEMED CORP | 18.44 | 6.57B | ||
| OPCH | OPTION CARE HEALTH INC | 18.58 | 5.465B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PRPO
Company Profile
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. The company is headquartered in New Haven, Connecticut and currently employs 54 full-time employees. The company went IPO on 2000-07-18. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Company Info
PRECIPIO INC
4 Science Park
New Haven CONNECTICUT 06511 US
CEO: Ilan Danieli
Employees: 54
Phone: 12037877888
PRECIPIO INC / PRPO FAQ
What does PRPO do?
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. The company is headquartered in New Haven, Connecticut and currently employs 54 full-time employees. The company went IPO on 2000-07-18. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Can you provide the latest stock price for PRECIPIO INC?
The current stock price of PRPO is 23.39 USD. The price increased by 4.33% in the last trading session.
Does PRECIPIO INC pay dividends?
PRPO does not pay a dividend.
What is the ChartMill rating of PRECIPIO INC stock?
PRPO has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is PRECIPIO INC worth?
PRECIPIO INC (PRPO) has a market capitalization of 40.93M USD. This makes PRPO a Nano Cap stock.
Who owns PRECIPIO INC?
You can find the ownership structure of PRECIPIO INC (PRPO) on the Ownership tab.
What is the Short Interest ratio of PRECIPIO INC (PRPO) stock?
The outstanding short interest for PRECIPIO INC (PRPO) is 0.21% of its float.